GSK Hoping to Introduce Malaria Vaccine Shortly

British pharmaceutical giant GlaxoSmithKline has signaled its intention of coming out with a malaria vaccine.

British pharmaceutical giant GlaxoSmithKline has signaled its intention of coming out with a malaria vaccine after confirming that it has applied for an EU approval for its RTS,S vaccine.

Despite seeking approval in Europe, the company revealed that the vaccine will be used for treating malaria in children living in sub-Saharan Africa, though the mass vaccination program will begin in 2015 at the earliest.

Malaria - Causes, Symptoms, Diagnosis, Prevention, Treatment
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.

GSK revealed that trials of the vaccine have found it to halve the number of malaria cases among children between 5 and 17 months while it reduced the number of cases by a quarter in younger babies. Should GSK get the approval, it would be the world's first vaccine against malaria.

Stating that the vaccine could be crucial in reducing the number of deaths among children even if its effect wanes after some time, London School of Hygiene and Tropical Medicine’s Colin Sutherland said, “If you can protect kids in Africa—or partially protect them—for that period in life when they're at most risk of severe illness or death, then even if that protection wanes you've got them through the worst”.

Source-Medindia

About Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of mosquito breeding. Swamps, ponds and stagnated drainage provide optimal breeding ground for mosquitoes.

Fever / Pyrexia - Symptom Evaluation - Types - FAQs
Fever or Pyrexia is an elevation in normal body temperature. Causes of fever include infections, injury, cancers, inflammation, hormonal, metabolic and genetic diseases.